$8B Price Tag for PCOS; Tymlos Label Update; Genetic Obesity Tx Seeks New Approvals

Eli Lilly is voluntarily recalling one lot of the glucagon emergency kit for low blood sugar with an expiration of April 2022 due to loss of potency, the FDA announced.

The estimated cost to diagnose and treat women with polycystic ovary syndrome (PCOS) was $8 billion in the U.S. in 2020. “Although PCOS affects at least one in seven women and leads to over $8 billion in healthcare costs annually in the United States alone, it is frequently misunderstood or overlooked by clinicians and policymakers,” said study author Carrie Riestenberg, MD, of the University of California Los Angeles, in a statement. (Journal of Clinical Endocrinology & Metabolism)

After seeing positive findings in a pivotal clinical study, Retina-AI Health announced that it submitted an application to the FDA for clearance of the RETINA-AI Galaxy, its autonomous diabetic retinopathy screening device.

Losing weight also helped to preserve fertility in boys with obesity ages 10 to 18, reversing alterations of Leydig cells. (U.S. News & World Report)

Radius Health announced a label update for the postmenopausal osteoporosis treatment abaloparatide (Tymlos) to include new data on the drug’s mechanism of action, which now reads: “Once-daily administration of abaloparatide stimulates new bone formation on trabecular and cortical bone surfaces by stimulation of osteoblastic activity.”

Metformin was able to extend pregnancy by about another week in women with preterm pre-eclampsia. (The BMJ)

A new review supported intermittent fasting — only eating within an 8- to 10-hour window each day — as a viable method for weight and metabolic control. (Endocrine Reviews)

Rhythm Pharmaceuticals announced that it submitted a supplemental new drug application to the FDA seeking an expanded indication for its melanocortin 4 receptor (MC4R) agonist setmelanotide (Imcivree) to also include patients with Bardet-Biedl syndrome or Alström syndrome.

In related news, Rhythm also said that setmelanotide (Imcivree) — already FDA approved back in 2020 — has now been given the green light in Great Britain, indicated for chronic weight management in patients ages 6 and older with obesity due to confirmed POMC, PCSK1, or LEPR deficiency.

Bayer announced that its new FIND-CKD trial — a phase III study testing finerenone (Kerendia) on the progression of nondiabetic chronic kidney disease — is now underway. The anti-mineralocorticoid agent was approved in July to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attack, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.

Last Updated September 27, 2021

  • author

    Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
This Super Rugged Off-Road Camper Has a Suprisingly Luxe Interior thumbnail

This Super Rugged Off-Road Camper Has a Suprisingly Luxe Interior

If you're of the opinion that all camping trailers look the same, you've obviously never seen a Bruder. The Australian-based company makes rugged military-like camping vehicles that can take on the toughest terrain in all seasons. Simply put, Bruders are pure beasts.In true Bruder fashion, the brand's newest model—the Bruder EXP-8 Off-Road Camper—is tough on…
Read More
SELECT: Semaglutide Reduces CV Events and Diabetes Risk thumbnail

SELECT: Semaglutide Reduces CV Events and Diabetes Risk

Please enable cookies. Error 1005 Ray ID: 899d1722cdb20e0c • 2024-06-26 12:09:46 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 899d1722cdb20e0c • Your IP: 185.124.111.116 •
Read More
Skin Care Tips for People With PAD, From a Dermatologist thumbnail

Skin Care Tips for People With PAD, From a Dermatologist

Please enable cookies. Error 1005 Ray ID: 84efeaa5ccf089e1 • 2024-02-02 05:08:29 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 84efeaa5ccf089e1 • Your IP: 89.117.245.16 •
Read More
Murders Surged in U.S. in 2020 thumbnail

Murders Surged in U.S. in 2020

By Cara MurezHealthDay ReporterMONDAY, Sept. 27, 2021 (HealthDay News) -- A record increase was seen in the number of murders in the United States in 2020, in the biggest one-year jump reported since federal officials began tracking homicides in 1960.Figures showed 4,901 more murders committed in 2020 than in 2019. A total of roughly 21,500…
Read More
Index Of News
Total
0
Share